Effect of anemia-correction on ultrasonic myocardial integrated backscatter in maintenance hemodialysis patients

FANG Yi,DING Xiao-qiang,ZHONG Yi-hong,ZOU Jian-zhou,LIU Shi-zhen,SHU Xian-hong,HUANG Guo-qian

2006-01-01

Abstract:Objective To measure the ultrasonic backscatter parameters of myocardium in maintenance hemodialysis (MHD) patients and to evaluate the effects of anemia-correction on the patients' myocardial properties. Methods Forty-five maintenance hemodialysis patients whose blood pressure were in good control and 15 healthy volunteers (M:F 10:5)were involved, with 30 anemia (M:F 20:10)and 15 non-anemia (M:F 10:5). With a history of 3 to 6 months maintenance hemodialysis, all the patients undertook echocardiography for ultrasonic tissue characterization at the beginning of the study and at the end of one-year follow-up. Following the initial echocardiography, anemic patients were randomly divided into two subgroups, one was to correct anemia within the first 3 months and to maintain it, the other was to keep a hemoglobin below 100 g/L. Non-anemic patients maintained their hemoglobin level within the normal range. During the follow-up, all patients' blood pressure were kept in good control in each group. Results At the beginning of the study, the value of the average integrated backscatter (AIB) and the cyclic variation of integrated backscatter (CVIB) was 6.21±0.22 and 9.88±0.61 in non-anemia group, 8.20±0.19 and 7.87±0.51 in anemia group, 5.94±0.21 and 10.52±0.86 in control gourp respectively. After one year's therapy, ultrasonicbackscatter parameters (AIB and CVIB) in anemia-corrected subgroup were improved, but the values were still different from those of the control group. As for the anemia-uncorrected subgroup, its AIB was elevated while CVIB was reduced compared with the initial values. There was no significant change in non-anemic group. Conclusions Anemic hemodialysis patients have a higher intergrated backscatter value than non-anemic patients, while non-anemic, non- hypertensive patients have a similar ultrasonic integrated values to the healthy people. Anemia may be one of the major factors contributing to myocardial fibrosis in the early stage of cardiomyopathy.